Cargando…
Psoriasis and Gut Microbiome—Current State of Art
Psoriasis is a chronic, immune-mediated inflammatory disease that affects around 125 million people worldwide. Several studies concerning the gut microbiota composition and its role in disease pathogenesis recently demonstrated significant alterations among psoriatic patients. Certain parameters suc...
Autores principales: | Polak, Karina, Bergler-Czop, Beata, Szczepanek, Michał, Wojciechowska, Kamila, Frątczak, Aleksandra, Kiss, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123672/ https://www.ncbi.nlm.nih.gov/pubmed/33926088 http://dx.doi.org/10.3390/ijms22094529 |
Ejemplares similares
-
Microbiome Modulation as a Therapeutic Approach in Chronic Skin Diseases
por: Polak, Karina, et al.
Publicado: (2021) -
Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis
por: Frątczak, Aleksandra, et al.
Publicado: (2023) -
When misery loves company: dissecting cellulitis of the scalp – a case report of follicular occlusion triad
por: Frątczak, Aleksandra, et al.
Publicado: (2022) -
The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the pathophysiology of psoriasis and systemic lupus erythematosus
por: Frątczak, Aleksandra, et al.
Publicado: (2022) -
Vitamin D—The Nutritional Status of Post-Gastrectomy Gastric Cancer Patients—Systematic Review
por: Muszyński, Tomasz, et al.
Publicado: (2022)